Towards cross-Canada monitoring of the unregulated street drug supply

[1]  R. Purssell,et al.  Crystal methamphetamine use in British Columbia, Canada: A cross-sectional study of people who access harm reduction services , 2021, PloS one.

[2]  T. Kerr,et al.  Examining factors that shape use and access to diverted prescription opioids during an overdose crisis: A qualitative study in Vancouver, Canada. , 2021, Journal of substance abuse treatment.

[3]  Lewis S. Nelson,et al.  Levamisole - A Toxic Adulterant in Illicit Drug Preparations: A Review. , 2020, Therapeutic drug monitoring.

[4]  A. Slaunwhite,et al.  Convenience and comfort: reasons reported for using drugs alone among clients of harm reduction sites in British Columbia, Canada , 2020, Harm Reduction Journal.

[5]  Amy S. Billing,et al.  Notes from the Field: High Prevalence of Fentanyl Detected by the Maryland Emergency Department Drug Surveillance System — Baltimore, Maryland, 2019 , 2020, MMWR. Morbidity and mortality weekly report.

[6]  P. Seth,et al.  Drug and Opioid-Involved Overdose Deaths — United States, 2017–2018 , 2020, MMWR. Morbidity and mortality weekly report.

[7]  K. Papamihali,et al.  Known fentanyl use among clients of harm reduction sites in British Columbia, Canada. , 2020, The International journal on drug policy.

[8]  S. Sherman,et al.  An assessment of the limits of detection, sensitivity and specificity of three devices for public health-based drug checking of fentanyl in street-acquired samples. , 2020, The International journal on drug policy.

[9]  T. Cicero,et al.  Polysubstance Use: A Broader Understanding of Substance Use During the Opioid Crisis. , 2019, American journal of public health.

[10]  H. Shulha,et al.  Initiation into heroin use among street-involved youth in a Canadian setting: A longitudinal cohort study. , 2019, Drug and alcohol dependence.

[11]  Joshua Montgomery,et al.  The Emerging Role of Toxic Adulterants in Street Drugs in the US Illicit Opioid Crisis , 2019, Public health reports.

[12]  V. Tsang,et al.  Acceptability of Technological Solutions for Overdose Monitoring: Perspectives of People who Use Drugs , 2019, Substance abuse.

[13]  K. Papamihali,et al.  Correlates of take-home naloxone kit possession among people who use drugs in British Columbia: A cross-sectional analysis. , 2019, Drug and alcohol dependence.

[14]  S. Allen,et al.  Patterns of polysubstance use and overdose among people who inject drugs in Baltimore, Maryland: A latent class analysis. , 2019, Drug and alcohol dependence.

[15]  R. Purssell,et al.  The British Columbia Drug Overdose and Alert Partnership: Interpreting and sharing timely illicit drug information to reduce harms , 2019, Journal of Community Safety and Well-Being.

[16]  B. Wallace,et al.  The implementation of overdose prevention sites as a novel and nimble response during an illegal drug overdose public health emergency. , 2019, The International journal on drug policy.

[17]  Thomas Kerr,et al.  Evaluation of a fentanyl drug checking service for clients of a supervised injection facility, Vancouver, Canada , 2018, Harm Reduction Journal.

[18]  T. Gomes,et al.  Contributions of prescribed and non-prescribed opioids to opioid related deaths: population based cohort study in Ontario, Canada , 2018, British Medical Journal.

[19]  E. Wood,et al.  Fentanyl and heroin contained in seized illicit drugs and overdose-related deaths in British Columbia, Canada: An observational analysis. , 2018, Drug and alcohol dependence.

[20]  C. Cherpitel,et al.  Recall bias across 7 days in self‐reported alcohol consumption prior to injury among emergency department patients , 2018, Drug and alcohol review.

[21]  Jill Barr-Walker,et al.  Fentanyl, fentanyl analogs and novel synthetic opioids: A comprehensive review , 2017, Neuropharmacology.

[22]  M. Alary,et al.  Drug use practices among people who inject drugs in a context of drug market changes: Challenges for optimal coverage of harm reduction programs. , 2017, The International journal on drug policy.

[23]  T. Wild,et al.  Perceived unmet need and barriers to care amongst street‐involved people who use illicit drugs , 2017, Drug and alcohol review.

[24]  Lisa Raville,et al.  Heroin and Methamphetamine Injection: An Emerging Drug Use Pattern , 2017, Substance use & misuse.

[25]  B. Venhuis,et al.  Adverse effects of levamisole in cocaine users: a review and risk assessment , 2017, Archives of Toxicology.

[26]  J. Montaner,et al.  The Impact of Benzodiazepine Use on Mortality among Polysubstance Users in Vancouver, Canada , 2016, Public health reports.

[27]  J. Buxton,et al.  Patient perspectives of methadone formulation change in British Columbia, Canada: outcomes of a provincial survey , 2016, Substance Abuse Treatment, Prevention, and Policy.

[28]  J. Buxton,et al.  Why the FUSS (Fentanyl Urine Screen Study)? A cross-sectional survey to characterize an emerging threat to people who use drugs in British Columbia, Canada , 2015, Harm Reduction Journal.

[29]  M. Gullo,et al.  Polysubstance use: diagnostic challenges, patterns of use and health , 2014, Current opinion in psychiatry.

[30]  J. Buxton,et al.  A drug use survey among clients of harm reduction sites across British Columbia, Canada, 2012 , 2014, Harm Reduction Journal.

[31]  M. Alary,et al.  Prevalence and temporal trends of crack injection among injection drug users in eastern central Canada. , 2013, Drug and alcohol dependence.

[32]  J. Bruneau,et al.  Patterns of cocaine and opioid co-use and polyroutes of administration among street-based cocaine users in Montréal, Canada. , 2013, The International journal on drug policy.

[33]  Rachel Morello-Frosch,et al.  The Three R's: How Community Based Participatory Research Strengthens the Rigor, Relevance and Reach of Science. , 2013, Environmental justice.

[34]  J. Boivin,et al.  Injection of drug residue as a potential risk factor for HCV acquisition among Montréal young injection drug users. , 2012, Drug and Alcohol Dependence.

[35]  Wayne Hall,et al.  Extent of illicit drug use and dependence, and their contribution to the global burden of disease , 2012, The Lancet.

[36]  J. Montaner,et al.  Difficulty accessing crack pipes and crack pipe sharing among people who use drugs in Vancouver, Canada , 2011, Substance abuse treatment, prevention, and policy.

[37]  M. Abrahamowicz,et al.  American Journal of Epidemiology Original Contribution Trends in Human Immunodeficiency Virus Incidence and Risk Behavior among Injection Drug Users in Montreal, Canada: a 16-year Longitudinal Study , 2022 .

[38]  Lewinda Knowles,et al.  Levamisole tainted cocaine causing severe neutropenia in Alberta and British Columbia , 2009, Harm reduction journal.

[39]  S. Macdonald,et al.  Non-response bias in alcohol and drug population surveys. , 2009, Drug and alcohol review.

[40]  D. Marsh,et al.  It's time for Canadian community early warning systems for illicit drug overdoses , 2007, Harm reduction journal.

[41]  J. Montaner,et al.  Evaluating methamphetamine use and risks of injection initiation among street youth: the ARYS study , 2006, Harm reduction journal.

[42]  M. Alary,et al.  Continuing HIV Transmission Among Injection Drug Users in Eastern Central Canada: The SurvUDI Study, 1995 to 2000 , 2002, Journal of acquired immune deficiency syndromes.

[43]  D. Payer,et al.  Adulterants, contaminants and co-occurring substances in drugs on the illegal market in Canada: an analysis of data from drug seizures, drug checking and urine toxicology. , 2020 .

[44]  J. Zibbell,et al.  Fentanyl test strips as an opioid overdose prevention strategy: Findings from a syringe services program in the Southeastern United States. , 2019, The International journal on drug policy.

[45]  Kelly C. Lee,et al.  Urine drug screening: practical guide for clinicians. , 2008, Mayo Clinic proceedings.

[46]  R. Volberg.  Gaming Policy and Enforcement Branch Ministry of Public Safety and Solicitor General , 2008 .

[47]  J. Montaner,et al.  Crystal methamphetamine use associated with non-fatal overdose among a cohort of injection drug users in Vancouver. , 2008, Public health.

[48]  F. Leri,et al.  Heroin and cocaine co-use in a group of injection drug users in Montréal. , 2004, Journal of psychiatry & neuroscience : JPN.

[49]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..